
Alivus Life Sciences Share Price
₹1,016.35 -39.05 (-3.7%)
22 Feb, 2025 22:44
Start SIP in
ALIVUS
Performance
- Low
- ₹992
- High
- ₹1,060
- 52 Week Low
- ₹677
- 52 Week High
- ₹1,335
- Open Price₹1,055
- Previous Close₹1,055
- Volume59,236
Investment Returns
- Over 1 Month -11.61%
- Over 3 Month -5.9%
- Over 6 Month -0.78%
- Over 1 Year + 15.91%
Smart Investing Starts Here Start SIP with Alivus Life Sciences for Steady Growth!
Alivus Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 28.2
- PEG Ratio
- -1.9
- Market Cap Cr
- 12,453
- P/B Ratio
- 4.9
- Average True Range
- 62.64
- EPS
- 36.05
- Dividend Yield
- 0
- MACD Signal
- -4.49
- RSI
- 40.53
- MFI
- 37.83
Alivus Life Sciences Financials
Alivus Life Sciences Technicals
EMA & SMA
Current Price
₹1,016.35
-39.05
(-3.7%)

-
- Bullish Moving Average 2
-
- Bearish Moving Average 14
- 20 Day
- ₹1,086.58
- 50 Day
- ₹1,088.42
- 100 Day
- ₹1,069.82
- 200 Day
- ₹1,008.49
Resistance and Support
1022.62
- R3 1,120.73
- R2 1,090.12
- R1 1,053.23
- S1 985.73
- S2 955.12
- S3 918.23
Alivus Life Sciences Corporate Actions - Bonus, Splits, Dividends
Alivus Life Sciences F&O
About Alivus Life Sciences
- NSE Symbol
- ALIVUS
- BSE Symbol
- 543322
- Managing Director & CEO
- Dr. Yasir Rawjee
- ISIN
- INE03Q201024
Similar Stocks to Alivus Life Sciences
Alivus Life Sciences FAQs
Alivus Life Sciences share price is ₹1,016 As on 22 February, 2025 | 22:30
The Market Cap of Alivus Life Sciences is ₹12453.2 Cr As on 22 February, 2025 | 22:30
The P/E ratio of Alivus Life Sciences is 28.2 As on 22 February, 2025 | 22:30
The PB ratio of Alivus Life Sciences is 4.9 As on 22 February, 2025 | 22:30
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.